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Abstract
This is a literature review and retrospective case series of acute idiopathic blind 
spot enlargement in two Caucasian females and one Hispanic male. Hallmark 
findings include unilateral photopsia, an enlarged blind spot, loss of the ellip-
soid and interdigitation zones on optical coherence tomography (OCT), and an 
abnormal multifocal electroretinography. This condition is an outer retinal dis-
ease that shares common traits with the acute zonal occult outer retinopathy 
(AZOOR) complex, which can confound the diagnosis. Autofluorescent imag-
ing may aid in differentiating the conditions. Dissemination of more case re-
ports detailing different presentations of this rare outer retinal disorder should 
help advance the clinical understanding of these conditions. 
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INTRODUCTION
Acute idiopathic blind spot enlargement (AIBSE), first described in 1988,1 is 
a rare condition that affects the peripapillary retina. It results in an acute-
onset scotoma contiguous with the physiological blind spot despite a lack of 
commensurate optic nerve swelling. The scotoma varies in size but general-
ly is an absolute defect with steep margins that does not progress over time. 
Fundus examination is often normal or only slightly abnormal, and there-
fore the condition is often diagnosed incorrectly.2–4 It is commonly misdi-
agnosed as optic neuritis due to the demographics and vision loss despite 
relatively normal ocular health or as a migraine aura due to photopsias. 
The etiology of AIBSE is unknown. Multiple mechanisms have been pro-
posed for outer retinal diseases, including an infectious or autoimmune eti-
ology.5 Hormonal or genetic factors may play a role.4 Patients are typically 
female between the ages of 19 and 53 years;4 however, the condition has 
been reported in males.1,3,6 Ethnicity is often not reported in the available 
case studies,4,7 but AIBSE has been reported in Caucasians8 and Asians.3,6 
In the largest series to date, Volpe et al.4 described 27 patients with AIBSE 
collected over an eight-year period. The most common symptom in patients 
with AIBSE was decreased vision (92%), categorized as blur, missing por-
tions of vision, spots in the vision, or the feeling of looking through a film.4 
Other symptoms include positive visual phenomenon (85%), such as photop-
sia, swirling, movement within the scotoma, colored lights, or a phenomenon 
similar to the afterimage seen after looking at a flash bulb. Visual acuity is 
normal in 60% of patients and, if abnormal, is between 20/25 and 20/50 in 
nearly all patients.4 Other clinical findings include mild optic nerve swelling 
(44%), dyschromatopsia (33%), relative afferent pupillary defect (30%), peri-
papillary pigment changes (22%), white retinal dots (18%), and peripapillary 
subretinal greyish discoloration (15%).4 Over time, chorioretinal scarring that 
corresponds to the visual field defect is likely to develop.9
Optical coherence tomography (OCT) will show loss of the ellipsoid zone and 
interdigitation line in the involved peripapillary area. Multifocal electroreti-
nography is essential in making the diagnosis of AIBSE. A full-field electro-
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retinogram will often be normal4 because it takes an average of the overall retinal activity, and the healthy retina will 
mask the abnormal readings. A focal or multifocal electroretinogram will demonstrate localized abnormalities that 
correlate with the visual field loss. The abnormalities on multifocal electroretinography will persist after other signs 
have resolved, and there may be bilateral abnormalities despite an otherwise unilateral presentation.9
Differential diagnoses that result in an enlarged blind spot include optic nerve head swelling (for example papilledema) 
causing anterior displacement of the peripapillary retina. In these cases, the size of the blind spot corresponds to a visible 
abnormality. Demyelinating optic neuritis, which is most common in young females, is an atypical cause of an enlarged 
blind spot. Ocular health is normal in two-thirds of these cases due to retrobulbar involvement. There is generally pain 
with eye movements, a significant relative afferent pupillary defect, and color vision deficits. OCT can be helpful in dif-
ferentiating demyelinating optic neuritis from AIBSE, as optic neuritis involves the inner retina (retinal ganglion cell 
and nerve fiber layer) and should not cause disruption of the outer retinal layers. With demyelinating optic neuritis, the 
results of multifocal electroretinography will be normal, since the test measures outer retinal function. Other differential 
diagnoses include autoimmune retinopathies, such as cancer-associated retinopathy or melanoma-associated retinopa-
thy, in which the fundus appears normal in early cases. These conditions will have a slower onset compared with AIBSE 
and progress without intervention.5 Additionally, high myopia can cause a slightly enlarged blind spot along with visible 
peripapillary abnormalities and symptoms of photopsia.
An enlarged blind spot due to outer retinal disease may be isolated, as in AIBSE, or associated with other conditions, 
including multiple evanescent white dot syndrome (MEWDS), acute macular neuroretinopathy, multifocal choroidi-
tis, punctate inner choroidopathy, acute annular outer retinopathy, and acute zonal occult outer retinopathy (AZOOR). 
Overlap between these conditions, all of which affect the outer retina and occur primarily in young or middle-aged 
women, has caused many to question whether the conditions are all variations of a single disease known as the AZOOR 
complex.3-5 Improved imaging devices and attention to minor differences may help distinguish the conditions.
There is no proven treatment for AIBSE. Photopsia should decrease over 3 to 4 months. The visual field loss may 
regress slightly, but generally does not completely resolve, although there are some reports to the contrary.4,9,10 The 
first report describing AIBSE reported resolution of symptoms within 2 to 3 months and a normal blind spot in 3 of 
the 7 patients.1 It has been argued that some of these patients may have represented late cases of MEWDS in which 
the fundus lesions had resolved.8 Volpe et al.4 followed-up 10 of the 27 patients in their case series; all had a decrease 
in photopsia, but there was no improvement in the blind spot in any of the 10 patients. Multifocal electroretinography 
defects may persist even if the visual field defect resolves and can be helpful in detecting subclinical retinal dysfunc-
tion.8 Recurrence is possible, albeit rare. 
Here we present three varying presentations of AIBSE to add to the existing case reports. The first case is a classic 
presentation of the condition. The second case, to the best of our knowledge, is the first reported case in a Hispanic 
male. The third case demonstrates the potential intermittent nature of the condition and has not yet been reported. 
These examples of this rare condition may help further define and classify the diagnosis of AIBSE.
CASE REPORTS
Case 1: A 28-year-old Caucasian female was referred to rule out demyelinating optic neuritis. She had sudden-onset, 
constant blurriness, and flashes of light in the temporal side of the vision in the left eye for two weeks. She had not expe-
rienced any recent fever or illness, she was not taking any medications, and she reported no pain with eye movements. 
Visual acuities were 20/20 right eye and 20/20-1 left eye. There was a mild relative afferent pupillary defect in the left eye. 
Pseudoisochromatic plates showed a mild red-green defect and 20% red desaturation in the left eye. The left fundus had 
mildly indistinct disc margins with a scleral and choroidal crescent (Fig. 1A). An optic nerve head OCT showed slightly 
increased peripapillary retinal nerve fiber layer thickness inferiorly in the left eye, and a macular OCT showed loss of 
the outer nuclear layer, external limiting membrane, ellipsoid zone, and interdigitation zone extending one-third of the 
distance between the temporal margin of the optic disc toward the fovea (Fig. 1B). Visual field analysis (Fig. 1C) dem-
onstrated a deep temporal scotoma surrounding the blind spot in the left eye. Magnetic resonance imaging (MRI) with 
contrast did not show any evidence of optic neuritis or demyelination. Multifocal electroretinography (Fig. 1D) showed 
significantly reduced amplitude and implicit time in the area corresponding to the visual field loss. Eight weeks later, the 
patient no longer experienced photopsia, but the visual field defect and outer retinal loss on OCT were stable. The left 
relative afferent pupillary defect remained.
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Figure 1: A 28-year-old Caucasian female with AIBSE in the left eye has mildly indistinct disc margins (A), loss of outer retinal 
layers adjacent to the optic nerve head on macular OCT (B), an enlarged blind spot (C), and significantly reduced amplitude and 
implicit time in the involved area with mfERG (D). All investigations of the uninvolved right eye were unremarkable.
Case 2: A 24-year-old Hispanic male had noted a constant circular black spot in the upper left corner of his vision 
nine days earlier. When he closed his eyes, the spot appeared as a greenish white light. He had not experienced a 
recent illness or flu-like symptoms. Ocular and medical history were unremarkable. He was taking no medications. 
Best correct visual acuities were 20/15 right eye and 20/15 left eye. There was no relative afferent pupillary defect, 
and color vision was normal. Posterior segment examination revealed a non-tilted horizontally elongated disc with 
an inferior scleral crescent in both eyes (Fig. 2A). Macular OCT showed loss of the external limiting membrane, 
ellipsoid zone, and interdigitation zone temporal to the optic disc (Fig. 2B) in the left eye. Visual field analysis (Fig. 
2C) demonstrated a deep temporal scotoma surrounding the blind spot in the left eye. Multifocal electroretinogra-
phy (Fig. 2D) showed significantly reduced amplitude and mildly reduced implicit time in the area corresponding to 
the visual field loss. Six weeks later, he noticed the spot less if both eyes were open. The visual field and multifocal 
electroretinography were similar to the previous readings. Two years after the initial event, the patient reported 
that the spot was still present, but he did not notice it unless he closed the right eye. Although some differences 
could be attributed to using different testing strategies, a small scotoma contiguous with the blind spot in the left 
eye remained (Fig. 2E). The left eye showed significant hypoautofluorescence in the peripapillary area without any 
significant hyperautofluorescence (Fig. 2F). The area of decreased amplitude on multifocal electroretinography was 
smaller (Fig. 2G). No evident change was present on OCT. 
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Figure 2: A 24-year-old Hispanic male with AIBSE in the left eye has horizontally elongated optic nerves with an inferior scleral 
crescent in both eyes (A), loss of outer retinal layers on macular OCT (B), an enlarged blind spot (C), and significantly reduced 
amplitude and implicit time with mfERG (D) in the left eye only. Two years later, a persistent small scotoma remains in the left 
eye (E). Fundus autofluorescence (F) shows hypoautofluorescence in the area of the scleral crescent in both eyes with a slight 
hyperautofluorescent crescent nasally in the right eye, and a smaller area of decreased amplitude remains in the left eye on mfERG (G). 
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Case 3: A 24-year-old Caucasian female noticed a shimmering area in the temporal field of the right eye on and off 
for three years. The shimmering lasted about 15 seconds and was followed by a blind spot in the same area that would 
last a couple of hours. Medical health was unremarkable, and she was taking levonorgestrel/ethinyl estradiol. Best 
corrected visual acuity was 20/15 in each eye. There was no relative afferent pupillary defect, and color vision was 
normal. Before and after an episode, there was a 360-degree halo surrounding the right optic nerve (Fig. 3A). During 
an episode, the peripapillary halo became larger (Fig. 3B) and the blind spot was enlarged slightly in the right eye (Fig. 
3C). Before and after the episode, the visual fields were unremarkable. Between episodes, a 5-line raster showed a 
small area of disruption of the ellipsoid and interdigitation zones temporal to the optic nerve in the right eye, whereas 
the corresponding area in the left eye was unremarkable (Fig. 3D). Multifocal electroretinography performed between 
episodes showed normal amplitude and implicit time; however, responses from the nasal retina of the right eye were 
reduced and slightly delayed relative to the remainder of the responses from that eye (Fig. 4E).
Figure 3: A 24-year-old Caucasian female with intermittent AIBSE in the right eye. Fundus photos before (A) and during (B) 
an episode show increased grey halo surrounding the optic nerve head during the episode. There is an enlarged blind spot in the 
right eye during an episode (C). There is a small area of disruption of the outer retinal layers just temporal to the optic nerve in 
the right eye (D) and relatively reduced and slightly delayed responses in nasal retina of the right eye with mfERG (E). 
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Figure 4: Multiple scattered white-dot lesions in the right eye (A) associated with MEWDS. Following resolution of the white 
dots, there is macular pigment granularity in the right eye (B). Macular OCT (C) shows involvement of the ellipsoid zone and 
interdigitation zone at the fovea of the right eye. Multifocal ERG (D) shows an area of reduced amplitude extending nasally 
from the fovea in the right eye.
DISCUSSION
Acute idiopathic blind spot enlargement (AIBSE) is a rare condition. Here we add three cases of AIBSE to the existing 
literature. The first case is representative of a classic presentation of AIBSE, although it again verifies that the condi-
tion continues to be misdiagnosed, as it was initially diagnosed as demyelinating optic neuritis. The second and third 
cases had no diagnosis at the time of referral. The second case is unusual in that it occurred in a Hispanic male; most 
reported cases of AIBSE occur in young Caucasian females. To our knowledge, this is the first reported case of AIBSE 
in a Hispanic male patient. Finally, with the third case, we add an unusual presentation of intermittent AIBSE. 
As seen in all three of these cases of AIBSE, the optic disc often has an abnormal appearance, such as congested 
disc or mild disc edema.9 Two of the three patients (Cases 1 and 3) had mild disc edema and a greyish peripapil-
lary halo. Interestingly, the greyish area significantly enlarged during the intermittent events in Case 3. Two of the 
cases involved a horizontally elongated nerve with significant peripapillary atrophy. In all three cases, peripapillary 
changes in the involved eye were greater than those in the non-involved eye. 
Consistent with outer retinopathy, our presented cases showed abnormal multifocal electroretinography corre-
sponding to the visual field loss. All cases showed both reduced amplitude and implicit time. Interestingly, in Case 
3, which exhibited intermittent AIBSE, multifocal electroretinography showed abnormalities between episodes de-
spite the patient having no symptoms or visual field loss. In addition to multifocal electroretinography defects, the 
other critical diagnostic feature of AIBSE, outer retinal abnormalities, including loss of the ellipsoid and interdigita-
tion zones noted on OCT, was present in all patients.
There continues to be debate over whether AIBSE is a distinct condition or simply a subset of the AZOOR complex. AIBSE, 
MEWDS, and AZOOR share common features. The conditions are more common in females and present with photop-
sias. The visual field loss in AZOOR may or may not be contiguous with the blind spot. With AZOOR, there is generally 
progression of the visual field loss and retinal anomalies over weeks or months, whereas the visual field loss with AIBSE 
typically remains stable. The retinal defects are bilateral in 39% of AZOOR cases,5 while AIBSE is generally unilateral.4,6 Of 
our presented cases, all had non-progressive, unilateral scotoma, which is more consistent with AIBSE than with AZOOR. 
The widespread availability of autofluorescence is relatively new, and therefore few cases demonstrate the defects pro-
duced by AIBSE. Areas of hyperautofluorescence indicate distress of the RPE while areas of hypoautofluorescence indi-
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cate death of RPE. Therefore, this technology may be helpful in differentiating AIBSE from AZOOR. With AZOOR, there 
will be a patchy hyperautofluorescent signal in the involved area that progresses over time.11 On fundus examination, there 
is a demarcating line around the involved area, typically orange in color, that is better seen on autofluorescent imaging.11 
This hyperautofluorescent line which demarcates the normal and involved retina is a defining feature of AZOOR.11 In ad-
dition to frequent zonal progression, Mrejen and colleagues11 proposed the following fundus autofluorescence criteria to 
diagnose AZOOR: a narrow hyperautofluorescent demarcation line between the involved and uninvolved retina and a tri-
zonal pattern of degeneration. The trizonal pattern can be seen on autofluorescence as an area of normal autofluorescence 
outside the involved region (zone 1), an area of hyperautofluorescence (zone 2), and an area of hypoautofluorescence (zone 
3). In Case 2, in which autofluorescent imaging was performed, no hyperautofluorescent line demarcating the abnormal 
tissue or trizonal pattern was present. There was significantly more peripapillary hypoautofluorescence in the involved 
eye compared to the normal eye, corresponding to the area of peripapillary atrophy. The signal was brighter surrounding 
the optic nerve, but this appears to be equal in both eyes. In AZOOR patients, the trizonal pattern can also be seen on OCT 
as a normal area outside the involved tissue (zone 1), a zone of subretinal drusenoid deposits (zone 2), and a zone of loss of 
photoreceptors (zone 3). This pattern was not present in any of the AIBSE patients in this report. The lack of the trizonal 
pattern with either autofluorescence or OCT may lend credence to AIBSE being a separate condition. 
AIBSE has features similar to MEWDS, and some argue that the characteristic white dots in the latter are not visible 
or have resolved in AIBSE. MEWDS is generally preceded by a viral-type illness and involves white lesions at the level 
of the photoreceptors that are visible for a few weeks (Fig. 4A). Vision normally recovers fully, but after resolution, 
the patient develops permanent macular pigment granularity that is considered pathognomonic of MEWDS (Fig. 4B). 
Despite seeing these patients in the acute stage, none had retinal white dots and all denied viral-type symptoms. In 
addition, macular granularity was not present in any of our cases. 
It has been proposed that if the scotoma surrounding the blind spot regresses, this is suggestive of a diagnosis of 
MEWDS, whereas peripapillary atrophy along with scotoma persistence leads to a diagnosis of multifocal chorio-
retinitis, and progression of the scotoma is indicative of AZOOR.10 Unfortunately, this classification does not take into 
account other characteristic features. Multifocal chorioretinitis is associated with anterior uveitis, as well as the pres-
ence of multiple yellow-gray choroidal lesions that become punched out scars over time. Despite no resolution or 
progression, none of the three cases had retinal lesions consistent with these features of multifocal chorioretinitis. 
CONCLUSION
Although AIBSE is poorly understood, it is important that eye care practitioners be familiar with its characteristics. 
Additional examples of this rare condition may help to define and classify the diagnosis. Our cases are not consistent 
with other outer retinopathies and may indicate that AIBSE is a separate condition from AZOOR or MEWDS. A 
nonprogressive unilateral enlarged blind spot with corresponding findings on multifocal electroretinography with-
out other indications of other outer retinal disorders is consistent with a diagnosis of AIBSE. Generally, the patient 
will have acute symptoms of vision loss and photopsia within the temporal field. The symptoms generally improve 
over time, but the visual field and multifocal electroretinography abnormalities remain. l
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